首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

2038383

2026 年至 2035 年睡眠呼吸中止症治療設備市場的商業機會、成長要素、產業趨勢和預測。

Sleep Apnea Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035

出版日期: 2026年04月27日 | 出版商:

Global Market Insights Inc. | 英文 176 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球睡眠呼吸中止治療設備市場價值為 93 億美元，預計到 2035 年將以 7.2% 的複合年成長率成長至 187 億美元。

睡眠呼吸中止症治療設備產業正經歷穩定成長，這主要得益於睡眠呼吸障礙盛行率的上升、公眾意識的提高以及技術的不斷創新。對小型化、高效、高性能治療方案日益成長的需求正在改變市場格局。老年人口的成長進一步加速了此類設備的普及，因為與老齡化相關的疾病是導致睡眠障礙的重要因素。同時，醫療機構和市場參與企業加強宣傳力度，提高了診斷和治療率。無線連接、雲端平台和行動監測等先進技術的整合，增強了患者的參與度，並實現了遠端醫療管理。這些進步使得治療依從性和有效性的即時追蹤成為可能，從而改善了長期治療效果。睡眠呼吸中止症治療設備在維持氣道完整性、改善氧氣輸送和提高睡眠品質方面發揮著至關重要的作用，從而最大限度地降低相關健康風險，並促進患者的整體健康。

市場範圍
開始年份	2025
預測期	2026-2035
上市時的市場規模	93億美元
預測金額	187億美元
複合年成長率	7.2%

治療設備領域在不斷創新的推動下，旨在提高治療的舒適性和有效性，預計到 2025 年將佔據 66.3% 的市場佔有率。先進的治療設備提高了易用性和性能，有助於提高患者的依從性，並實現長期治療的成功。

預計睡眠檢查室和醫院領域將以6.3%的複合年成長率成長，到2035年達到70億美元。該領域的成長主要受臨床管理診斷和治療解決方案需求不斷成長的驅動。對精準診斷和系統化治療方案的需求持續推動醫療機構的擴張。

預計2025年，美國睡眠呼吸中止症治療設備市場規模將達39億美元。市場成長主要得益於有利的醫保報銷政策和便捷診斷方法的普及。檢測和治療方案的日益普及提高了患者的參與度，並擴大了市場覆蓋範圍。

研究途徑
品質改進計劃
- GMI人工智慧政策及對資料完整性的承諾
  - 資訊來源一致性協議
調查過程和可靠性評分
- 研究路徑的組成部分
- 評分組成部分
數據收集
- 主要來源部分列表
資料探勘資訊來源
- 付費資訊來源
  - 區域資訊來源
基本估算和計算方法
- 基準年的計算
預測模型
- 量化市場影響分析
  - 生長參數對預測的數學影響
關於調查透明度的補充信息
- 資訊來源歸屬框架
- 品質保證指標
- 對信任的承諾

第2章執行摘要

第3章業界考察

生態系分析
影響產業的因素
- 促進因素
  - 睡眠呼吸中止症及相關合併症發生率增加
  - 市場對攜帶式、高效能睡眠呼吸中止症解決方案的需求日益成長
  - 人們對睡眠呼吸中止症和睡眠障礙的認知不斷提高
  - 人口老化導致需求增加。
  - 技術進步
- 產業潛在風險與挑戰
  - 睡眠呼吸中止症治療依從性不足
  - 產品召回與安全問題
- 機會
  - 進入新興市場
  - 人工智慧與數位健康的融合
成長潛力分析
監理情勢（基於初步調查）
- 北美洲
- 歐洲
- 亞太地區
科技與創新趨勢
- 當前技術趨勢
- 新興技術
未來市場趨勢（基於初步研究）
救贖方案
差距分析
波特五力分析
PESTEL 分析

第4章競爭情勢

介紹
- SOMNOMED LIMITED
- 費雪派克醫療保健
- ResMed Inc.
企業矩陣分析
企業市佔率分析（基於初步研究）
- 世界
- 北美洲
- 歐洲
- 亞太地區
- 拉丁美洲
- 中東和非洲（MEA）
主要市場公司的競爭分析
競爭定位矩陣
主要進展
- 併購
- 夥伴關係和聯盟
- 新產品發布
- 業務拓展計劃

第5章市場估價與預測：依產品分類，2022-2035年

治療設備
- 正壓通氣（PAP）裝置
  - 持續性陽壓呼吸器（CPAP）裝置
  - 自動正壓通氣（APAP）裝置
  - 雙級正壓通氣（BiPAP）裝置
- 口內矯正器
  - 下顎前突裝置
  - 舌固定裝置
- 自適應伺服通風（ASV）系統
- 呼吸道清潔系統
- 其他治療產品
診斷設備
- 居家睡眠監測（HST）設備
  - 類型 2
  - 3型
  - 4型
- 睡眠多導圖（PSG）設備
  - 臨床多導睡眠圖設備
  - 攜帶式多導睡眠圖儀
- 腕動計系統
- 其他診斷設備

第6章市場估算與預測：依最終用途分類，2022-2035年

居家照護機構及個人
睡眠檢查室和醫院

第7章市場估計與預測：依地區分類，2022-2035年

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲（MEA）
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第8章：公司簡介

Apnea Sciences
Asahi KASEI
BMC
Cadwell
Drive DeVilbiss
DynaFlex
FISHER & PAYKEL
Glidewell
natus
NIHON KOHDEN
Philips
ResMed
SomnoMed
Teleflex
WEINMANN

簡介目錄

Product Code: 489

The Global Sleep Apnea Devices Market was valued at USD 9.3 billion in 2025 and is estimated to grow at a CAGR of 7.2% to reach USD 18.7 billion by 2035.

The sleep apnea devices industry is experiencing steady expansion due to the increasing prevalence of sleep-related breathing disorders, rising awareness levels, and continuous technological innovation. Growing demand for compact, efficient, and high-performance therapeutic solutions is reshaping the market landscape. The rising geriatric population is further accelerating adoption, as age-related conditions significantly contribute to sleep disorders. In parallel, increasing educational initiatives by healthcare institutions and industry participants are improving diagnosis and treatment rates. Integration of advanced technologies, including wireless connectivity, cloud-based platforms, and mobile-enabled monitoring, is enhancing patient engagement and enabling remote therapy management. These advancements allow real-time tracking of treatment adherence and effectiveness, improving long-term outcomes. Sleep apnea devices play a crucial role in maintaining airway patency, improving oxygen supply, and enhancing sleep quality, thereby minimizing associated health risks and supporting overall patient well-being.

Market Scope
Start Year	2025
Forecast Year	2026-2035
Start Value	$9.3 Billion
Forecast Value	$18.7 Billion
CAGR	7.2%

The therapeutics segment held a share of 66.3% in 2025, supported by continuous innovation aimed at improving treatment comfort and effectiveness. Advanced therapeutic devices now incorporate enhanced usability features and improved performance capabilities, contributing to better patient compliance and long-term therapy success.

The sleep laboratories and hospitals segment is anticipated to grow at a CAGR of 6.3%, reaching USD 7 billion by 2035. Growth in this segment is driven by increasing demand for clinically supervised diagnostic and treatment solutions. The need for accurate diagnosis and structured treatment pathways continues to support expansion across healthcare facilities.

U.S. Sleep Apnea Devices Market was valued at USD 3.9 billion in 2025. Market growth is supported by favorable reimbursement frameworks and increasing adoption of convenient diagnostic approaches. The shift toward accessible testing and treatment solutions is enhancing patient participation and expanding overall market reach.

Key players involved in the Global Sleep Apnea Devices Market include Apnea Sciences, Asahi KASEI, BMC, Cadwell, Drive DeVilbiss, DynaFlex, FISHER & PAYKEL, Glidewell, natus, NIHON KOHDEN, Philips, ResMed, SomnoMed, Teleflex, WEINMANN Top of FormBottom of Form. Companies in the Sleep Apnea Devices Market are focusing on innovation, strategic partnerships, and product portfolio expansion to strengthen their competitive position. Manufacturers are investing heavily in research and development to introduce technologically advanced and patient-friendly devices. Integration of digital health capabilities, including remote monitoring and data analytics, is becoming a key differentiator. Firms are also pursuing collaborations with healthcare providers and distributors to expand their global footprint. In addition, companies are emphasizing cost optimization, regulatory compliance, and improved supply chain efficiency to enhance accessibility and market penetration. Continuous focus on user-centric design and long-term therapy effectiveness is further supporting sustained growth and brand loyalty.

Chapter 1 Research Methodology

1.1 Research approach
1.2 Quality commitments
- 1.2.1 GMI AI policy & data integrity commitment
  - 1.2.1.1 Source consistency protocol
1.3 Research trail & confidence scoring
- 1.3.1 Research trail components
- 1.3.2 Scoring components
1.4 Data collection
- 1.4.1 Partial list of primary sources
1.5 Data mining sources
- 1.5.1 Paid sources
  - 1.5.1.1 Sources, by region
1.6 Base estimates and calculations
- 1.6.1 Base year calculation
1.7 Forecast model
- 1.7.1 Quantified market impact analysis
  - 1.7.1.1 Mathematical impact of growth parameters on forecast
1.8 Research transparency addendum
- 1.8.1 Source attribution framework
- 1.8.2 Quality assurance metrics
- 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

2.1 Industry 360° synopsis
2.2 Key market trends
- 2.2.1 Regional trends
- 2.2.2 Product trends
- 2.2.3 End use trends
2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing incidence of sleep apnea and related comorbidities
  - 3.2.1.2 Growing demand for portable, high-performance sleep apnea solutions
  - 3.2.1.3 Surging awareness of sleep apnea and sleep disorders
  - 3.2.1.4 The rising aging population amplifying demand
  - 3.2.1.5 Technological advancements
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Lack of adherence to sleep apnea treatment
  - 3.2.2.2 Product recalls and safety concerns
- 3.2.3 Opportunities
  - 3.2.3.1 Expansion into emerging markets
  - 3.2.3.2 AI and digital health integration
3.3 Growth potential analysis
3.4 Regulatory landscape (Driven by Primary Research)
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
3.5 Technology and innovation landscape
- 3.5.1 Current technological trends
- 3.5.2 Emerging technologies
3.6 Future market trends (Driven by Primary Research)
3.7 Reimbursement scenario
3.8 Gap analysis
3.9 Porter's analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

4.1 Introduction
- 4.1.1 SOMNOMED LIMITED
- 4.1.2 FISHER & PAYKEL Healthcare
- 4.1.3 ResMed Inc.
4.2 Company matrix analysis
4.3 Company market share analysis (Driven by Primary Research)
- 4.3.1 Global
- 4.3.2 North America
- 4.3.3 Europe
- 4.3.4 Asia Pacific
- 4.3.5 Latin America
- 4.3.6 MEA
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Key developments
- 4.6.1 Mergers & acquisitions
- 4.6.2 Partnerships & collaborations
- 4.6.3 New product launches
- 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

5.1 Key trends
5.2 Therapeutics
- 5.2.1 Positive airway pressure (PAP) devices
  - 5.2.1.1 Continuous positive airway pressure (CPAP) devices
  - 5.2.1.2 Automatic positive airway pressure (APAP) devices
  - 5.2.1.3 Bilevel positive airway pressure (BiPAP) devices
- 5.2.2 Oral appliances
  - 5.2.2.1 Mandibular advancement devices
  - 5.2.2.2 Tongue-retaining devices
- 5.2.3 Adaptive servo-ventilation (ASV) devices
- 5.2.4 Airway clearance systems
- 5.2.5 Other therapeutic products
5.3 Diagnostics
- 5.3.1 Home sleep testing (HST) devices
  - 5.3.1.1 Type 2
  - 5.3.1.2 Type 3
  - 5.3.1.3 Type 4
- 5.3.2 Polysomnography (PSG) device
  - 5.3.2.1 Clinical PSG devices
  - 5.3.2.2 Ambulatory PSG devices
- 5.3.3 Actigraphy systems
- 5.3.4 Other diagnostic devices

Chapter 6 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

6.1 Key trends
6.2 Home care settings and individuals
6.3 Sleep laboratories and hospitals

Chapter 7 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
7.6 MEA
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE